Dengli Hong

2.2k total citations
30 papers, 1.5k citations indexed

About

Dengli Hong is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Dengli Hong has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Hematology and 10 papers in Immunology. Recurrent topics in Dengli Hong's work include Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Immune Cell Function and Interaction (4 papers). Dengli Hong is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Immune Cell Function and Interaction (4 papers). Dengli Hong collaborates with scholars based in China, United Kingdom and Thailand. Dengli Hong's co-authors include Tariq Enver, Rajeev Gupta, Ann Atzberger, Shinobu Tsuzuki, Shamit Soneji, Mel Greaves, Christopher D. Buckley, Simon Kollnberger, Paul Bowness and Andrew Filer and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Dengli Hong

29 papers receiving 1.5k citations

Peers

Dengli Hong

HEMAT

IMMUN

ONCOL

PHEOH

Luisa Cimmino United States

Denis M. Schewe Germany

Haruko Shima Japan

Laura F. Newell United States

Philippe Quittet France

Claudia Benz Canada

Catherine Maillard Belgium

Diana Passaro United Kingdom

Carin Lassen Sweden

R Schirò Italy

Luisa Cimmino United States

Dengli Hong

843 ×1.2

304 ×0.6

HEMAT

257 ×0.6

IMMUN

182 ×0.6

ONCOL

151 ×0.6

PHEOH

Citations per year, relative to Dengli Hong Dengli Hong (= 1×) peers Luisa Cimmino

Countries citing papers authored by Dengli Hong

Since Specialization

Citations

This map shows the geographic impact of Dengli Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dengli Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dengli Hong more than expected).

Fields of papers citing papers by Dengli Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dengli Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dengli Hong. The network helps show where Dengli Hong may publish in the future.

Co-authorship network of co-authors of Dengli Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Dengli Hong. A scholar is included among the top collaborators of Dengli Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dengli Hong. Dengli Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hong, Dengli, et al.. (2024). The role of integrin-related genes in atherosclerosis complicated by abdominal aortic aneurysm. Medicine. 103(46). e40293–e40293.

Guo, Zengya, Xi‐Dai Long, Yingting Zhang, et al.. (2023). SIRT2 regulates extracellular vesicle-mediated liver–bone communication. Nature Metabolism. 5(5). 821–841. 56 indexed citations

Long, Jun, Xinjie Chen, Yan Shen, et al.. (2023). A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment. Cell Reports Medicine. 4(11). 101286–101286. 5 indexed citations

Zhu, Xiaona, Qian Yang, Haoran Liu, et al.. (2023). FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. Journal of Hematology & Oncology. 16(1). 9–9. 14 indexed citations

Dong, Xiao, Lili Mu, Si‐Cong Yang, et al.. (2020). Biomimetic, Hypoxia‐Responsive Nanoparticles Overcome Residual Chemoresistant Leukemic Cells with Co‐Targeting of Therapy‐Induced Bone Marrow Niches. Advanced Functional Materials. 30(12). 43 indexed citations

Li, Zhen, Ruoyan Li, Xia Liu, et al.. (2018). Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes. Cell Death and Disease. 9(5). 526–526. 8 indexed citations

Liu, Shan, Haiyan Liu, Qin Ru, et al.. (2017). The cellular senescence of leukemia-initiating cells from acute lymphoblastic leukemia is postponed by β-Arrestin1 binding with P300-Sp1 to regulate hTERT transcription. Cell Death and Disease. 8(4). e2756–e2756. 25 indexed citations

Martín‐Lorenzo, Alberto, María Begoña García Cenador, Sandra Pinto, et al.. (2017). Prolonged intracellular accumulation of light-inducible nanoparticles in leukemia cells allows their remote activation. Nature Communications. 8(1). 15204–15204. 23 indexed citations

Mu, Lili, et al.. (2017). Neoplasms in the bone marrow niches: disturbance of the microecosystem. International Journal of Hematology. 105(5). 558–565. 1 indexed citations

10.

Liu, Tianhui, Ying Huang, Hua Zhu, et al.. (2016). Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin. Leukemia. 31(5). 1079–1086. 7 indexed citations

11.

Liang, Yajun, Jing Hu, Jiatao Li, et al.. (2015). Epigenetic Activation of TWIST1 by MTDH Promotes Cancer Stem–like Cell Traits in Breast Cancer. Cancer Research. 75(17). 3672–3680. 77 indexed citations

12.

Duan, Cai‐Wen, Jun Shi, Jing Chen, et al.. (2014). Leukemia Propagating Cells Rebuild an Evolving Niche in Response to Therapy. Cancer Cell. 25(6). 778–793. 140 indexed citations

13.

Fan, Daiming, Xiaodong Zhou, Zhenghe Li, et al.. (2014). Stem cell programs are retained in human leukemic lymphoblasts. Oncogene. 34(16). 2083–2093. 6 indexed citations

14.

Wang, Lu, Tianhui Liu, Ya Gao, et al.. (2013). Fev regulates hematopoietic stem cell development via ERK signaling. Blood. 122(3). 367–375. 43 indexed citations

15.

He, Ming, Juan Tang, Ying Lu, et al.. (2012). HIF-1α downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation. Cell Death and Differentiation. 20(3). 408–418. 86 indexed citations

16.

Ford, Anthony M., Chiara Palmi, Clara Bueno, et al.. (2009). The TEL-AML1 leukemia fusion gene dysregulates the TGF-β pathway in early B lineage progenitor cells. Journal of Clinical Investigation. 119(4). 826–36. 88 indexed citations

17.

Hong, Dengli, Rajeev Gupta, Philip Ancliff, et al.. (2008). Initiating and Cancer-Propagating Cells in TEL-AML1 -Associated Childhood Leukemia. Science. 319(5861). 336–339. 260 indexed citations

18.

Pina, Cristina, Gillian May, Shamit Soneji, Dengli Hong, & Tariq Enver. (2008). MLLT3 Regulates Early Human Erythroid and Megakaryocytic Cell Fate. Cell stem cell. 2(3). 264–273. 54 indexed citations

19.

Tsuzuki, Shinobu, Dengli Hong, Rajeev Gupta, et al.. (2007). Isoform-Specific Potentiation of Stem and Progenitor Cell Engraftment by AML1/RUNX1. PLoS Medicine. 4(5). e172–e172. 65 indexed citations

20.

Enver, Tariq, Shinobu Tsuzuki, John Brown, et al.. (2005). Developmental Impact of Leukemic Fusion Genes on Stem Cell Fate. Annals of the New York Academy of Sciences. 1044(1). 16–23. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact